메뉴 건너뛰기




Volumn 15, Issue 2, 2013, Pages 63-78

The Italian Manifesto for the treatment of heroin addiction. The mixed care model a proposed layout for a new healthcare system for citizens with heroin addiction

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; METHADONE; OPIATE RECEPTOR;

EID: 84880148673     PISSN: 15921638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (10)

References (34)
  • 3
    • 80155183703 scopus 로고    scopus 로고
    • Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence
    • Amato L., Minozzi S., Davoli M., Vecchi S. (2011): Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev (10): CD004147.
    • (2011) Cochrane Database Syst Rev , vol.10
    • Amato, L.1    Minozzi, S.2    Davoli, M.3    Vecchi, S.4
  • 4
    • 77957265696 scopus 로고    scopus 로고
    • Australian Government, Therapeutic Goods Administration, Australian Public Assessment Report for Buprenorphine/ Naloxone. TGA health safety Regulation
    • Australian Government, Department of Health and Ageing, Therapeutic Goods Administration (2011): Australian Public Assessment Report for Buprenorphine/ Naloxone. TGA health safety Regulation, http://www.tga.gov.au/pdf/auspar/auspar-suboxone.pdf.
    • (2011) Department of Health and Ageing
  • 5
    • 4644227528 scopus 로고    scopus 로고
    • A pilot study of buprenorphine-naloxone combination tablet (Suboxone) in treatment of opioid dependence
    • Bell J., Byron G., Gibson A., Morris A. (2004): A pilot study of buprenorphine-naloxone combination tablet (Suboxone) in treatment of opioid dependence. Drug Alcohol Rev. 23(3): 311-317.
    • (2004) Drug Alcohol Rev , vol.23 , Issue.3 , pp. 311-317
    • Bell, J.1    Byron, G.2    Gibson, A.3    Morris, A.4
  • 6
    • 84995255600 scopus 로고
    • Philosophy and reality in methadone treatment
    • Desjarleis D. C. (1994): Philosophy and reality in methadone treatment. Addiction: 807-809.
    • (1994) Addiction , pp. 807-809
    • Desjarleis, D.C.1
  • 7
    • 27544457547 scopus 로고
    • A medical treatment for diacetylmorphine (heroin) addiction: A clinical trial with methadone hydrocloride
    • Dole V. P., Nyswander M. E. (1965): A medical treatment for diacetylmorphine (heroin) addiction: A clinical trial with methadone hydrocloride. JAMA. 193: 80-84.
    • (1965) JAMA , vol.193 , pp. 80-84
    • Dole, V.P.1    Nyswander, M.E.2
  • 9
    • 0242556465 scopus 로고    scopus 로고
    • Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroindependent volunteers
    • Greenwald M. K., Johanson C. E., Moody D. E., Woods J. H., Kilbourn M. R., Koeppe R. A., Schuster C. R., Zubieta J. K. (2003): Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroindependent volunteers. Neuropsychopharmacology. 28(11): 2000-2009.
    • (2003) Neuropsychopharmacology , vol.28 , Issue.11 , pp. 2000-2009
    • Greenwald, M.K.1    Johanson, C.E.2    Moody, D.E.3    Woods, J.H.4    Kilbourn, M.R.5    Koeppe, R.A.6    Schuster, C.R.7    Zubieta, J.K.8
  • 12
    • 34249338734 scopus 로고    scopus 로고
    • A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: A randomized controlled trial
    • Kakko J., Gronbladh L., Svanborg K. D., Von Wachenfeldt J., Ruck C., Rawlings B., Nilsson L. H., Heilig M. (2007): A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. Am J Psychiatry. 164(5): 797-803.
    • (2007) Am J Psychiatry , vol.164 , Issue.5 , pp. 797-803
    • Kakko, J.1    Gronbladh, L.2    Svanborg, K.D.3    von Wachenfeldt, J.4    Ruck, C.5    Rawlings, B.6    Nilsson, L.H.7    Heilig, M.8
  • 14
    • 56049124615 scopus 로고    scopus 로고
    • When a New Drug Promotes the Integration of Treatment Modalities: Suboxone and Harm Reduction
    • Maremmani I. (2008): When a New Drug Promotes the Integration of Treatment Modalities: Suboxone and Harm Reduction. Heroin Addict Relat Clin Probl. 10(3): 5-12.
    • (2008) Heroin Addict Relat Clin Probl , vol.10 , Issue.3 , pp. 5-12
    • Maremmani, I.1
  • 15
    • 84880154349 scopus 로고    scopus 로고
    • Heroin Dependence: Theory of Different Levels of Intervention
    • In: Maremmani I. (Ed.), Pacini Editore Medicina, Pisa
    • Maremmani I. (2009): Heroin Dependence: Theory of Different Levels of Intervention. In: Maremmani I. (Ed.) The Principles and Practice of Methadone Treatment. Pacini Editore Medicina, Pisa. pp. 31-38.
    • (2009) The Principles and Practice of Methadone Treatment , pp. 31-38
    • Maremmani, I.1
  • 19
    • 56049094331 scopus 로고    scopus 로고
    • Harm reduction and specific treatments for heroin addiction. Different approaches or levels of intervention?. An illness-centred perspective
    • Maremmani I., Pacini M., Lubrano S., Giuntoli G., Lovrecic M. (2002): Harm reduction and specific treatments for heroin addiction. Different approaches or levels of intervention?. An illness-centred perspective. Heroin Addict Relat Clin Probl. 4(3): 5-11.
    • (2002) Heroin Addict Relat Clin Probl , vol.4 , Issue.3 , pp. 5-11
    • Maremmani, I.1    Pacini, M.2    Lubrano, S.3    Giuntoli, G.4    Lovrecic, M.5
  • 21
    • 44949167587 scopus 로고    scopus 로고
    • Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
    • Mattick R. P., Kimber J., Breen C., Davoli M. (2008): Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev(2): CD002207.
    • (2008) Cochrane Database Syst Rev , vol.2
    • Mattick, R.P.1    Kimber, J.2    Breen, C.3    Davoli, M.4
  • 22
    • 0027407494 scopus 로고
    • The effects of psychosocial services in substance abuse treatment
    • Mclellan A. T., Arndt I. O., Metzger D. S., Woody G. E., O'brien C. P. (1993): The effects of psychosocial services in substance abuse treatment. JAMA. 269(15): 1953-1959.
    • (1993) JAMA , vol.269 , Issue.15 , pp. 1953-1959
    • McLellan, A.T.1    Arndt, I.O.2    Metzger, D.S.3    Woody, G.E.4    O'Brien, C.P.5
  • 23
    • 84876984133 scopus 로고    scopus 로고
    • The effects of a novel take-home treatment strategy in patients with opioid-dependence receiving long-term opioid replacement therapy with buprenorphine/naloxone in Italy: A cost analysis
    • Montesano F., Mellace V., On Behalf of Atc-Dpc Project Group (2013): The effects of a novel take-home treatment strategy in patients with opioid-dependence receiving long-term opioid replacement therapy with buprenorphine/naloxone in Italy: A cost analysis. Heroin Addict Relat Clin Probl. 15(1): 45-52.
    • Heroin Addict Relat Clin Probl , vol.15 , Issue.1 , pp. 45-52
    • Montesano, F.1    Mellace, V.2
  • 24
    • 84880142436 scopus 로고    scopus 로고
    • Methadone and buprenorphine for the management of opioid dependence
    • National Institute for Health and Clinical Excellence
    • National Institute for Health and Clinical Excellence (2010): Methadone and buprenorphine for the management of opioid dependence. NHS, http://www.nice.org.uk/nicemedia/pdf/TA114Niceguidance.pdf.
    • (2010) NHS
  • 25
    • 0003300292 scopus 로고
    • The Pharmacological Rationale for Methadone Treatment of Narcotic Addiction
    • In: Tagliamonte A., Maremmani I. (Eds.), Springer-Verlag, Wien New York
    • Newman R. G. (1995): The Pharmacological Rationale for Methadone Treatment of Narcotic Addiction. In: Tagliamonte A., Maremmani I. (Eds.): Drug Addiction and Related Clinical Problems. Springer-Verlag, Wien New York. pp. 109-118.
    • (1995) Drug Addiction and Related Clinical Problems , pp. 109-118
    • Newman, R.G.1
  • 26
    • 56049100243 scopus 로고
    • Starring Harm Reduction (Editorial)
    • O'hare P. (1994): Starring Harm Reduction (Editorial). Int J Drug Policy. 5: 199-200.
    • (1994) Int J Drug Policy , vol.5 , pp. 199-200
    • O'Hare, P.1
  • 29
    • 78049235506 scopus 로고    scopus 로고
    • The SUMMIT trial: A field comparison of buprenorphine versus methadone maintenance treatment
    • Pinto H., Maskrey V., Swift L., Rumball D., Wagle A., Holland R. (2010): The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment. J Subst Abuse Treat. 39(4): 340-352.
    • (2010) J Subst Abuse Treat , vol.39 , Issue.4 , pp. 340-352
    • Pinto, H.1    Maskrey, V.2    Swift, L.3    Rumball, D.4    Wagle, A.5    Holland, R.6
  • 30
    • 84880174321 scopus 로고    scopus 로고
    • Presidenza Del Consiglio Dei Ministri, L'integrazione M. P. L. C. I. E., Dipartimento Poliche Antidroga (2012): Relazione annuale al parlamento 2012. Sull'uso di sostanze stupefacenti e sulle tossicodipendenze in Italia. dati relativi all'anno 2011 e primo semestre 2012 - Elaborazioni 2012. Sintesi. Italian Government, accessed 2013/05/11
    • Presidenza Del Consiglio Dei Ministri, L'integrazione M. P. L. C. I. E., Dipartimento Poliche Antidroga (2012): Relazione annuale al parlamento 2012. Sull'uso di sostanze stupefacenti e sulle tossicodipendenze in Italia. dati relativi all'anno 2011 e primo semestre 2012 - Elaborazioni 2012. Sintesi. Italian Government, http://www.politicheantidroga.it/media/569861/filecumulativo_light.pdf (accessed 2013/05/11).
  • 31
    • 84880174041 scopus 로고    scopus 로고
    • Rand Europe, Ernst & Young Llp, University of Cambridge, National evaluation of the Department of Health's integrated care pilots. RAND Europe, Cambridge
    • Rand Europe, Ernst & Young Llp, University of Cambridge (2012): National evaluation of the Department of Health's integrated care pilots. RAND Europe, Cambridge.
    • (2012)
  • 32
    • 77952118055 scopus 로고    scopus 로고
    • Rb Pharmaceuticals Limited, Available at: wwwemaeuropaeu. Accessed on 16 February 2011
    • Rb Pharmaceuticals Limited (2011): Suboxone summary of product characteristics. Available at: wwwemaeuropaeu. Accessed on 16 February 2011.
    • (2011) Suboxone Summary of Product Characteristics
  • 33
    • 84880141237 scopus 로고    scopus 로고
    • Scottish Medicines Consortium, buprenorphine/ naloxone 2mg/0.5mg, 8/2mg sublingual tablet (Suboxone). NHS,
    • Scottish Medicines Consortium (2007): buprenorphine/ naloxone 2mg/0.5mg, 8/2mg sublingual tablet (Suboxone). NHS, http://www.scottishmedicines.org.uk/files/buprenorphine_naloxone_sublingual_tablet__Suboxone__355-07_.pdf.
    • (2007)
  • 34
    • 84995219008 scopus 로고
    • Methadone Maintenance Treatment: Harm reduction or rehabilitation?
    • Wells B. (1994): Methadone Maintenance Treatment: harm reduction or rehabilitation? Addiction. 89: 806.
    • (1994) Addiction , vol.89 , pp. 806
    • Wells, B.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.